• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Plasmacytoma

Plasmacytoma - 153 Studies Found

Completed : Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2007-07-10
:
  • Biological: CMV pp65 peptide G

Completed : Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2007-06-04
:
  • Biological: bevacizumab
  • Genetic: gene expr

Active, not recruiting : Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain
:
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Pain

: 2007-06-04
:
  • Drug: Pamidronate 90 mg by IV

Completed : Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2007-05-23
:
  • Drug: cyclophosphamide 300 mg/

Completed : Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2007-05-23
:
  • Drug: bortezomib
  • Other: immunologic techni

Active, not recruiting : Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2007-05-23
:
  • Biological: rituximab 375 mg/m

Completed : Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2007-05-23
:
  • Drug: lenalidomide

Completed : Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2007-05-03
:
  • Biological: recombinant interferon alfa
  • Bi

Completed : Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2007-04-09
:
  • Drug: bortezomib
  • Drug: dexamethasone

Completed : Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2007-03-07
:
  • Biological: pneumococcal polyvalent vaccine

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.